PMID- 36688194 OWN - NLM STAT- MEDLINE DCOM- 20230124 LR - 20230512 IS - 1735-3688 (Electronic) IS - 0253-0716 (Print) IS - 0253-0716 (Linking) VI - 48 IP - 1 DP - 2023 Jan TI - Association of Human Leukocyte Antigen Alleles with Carbamazepine- or Lamotrigine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in an Iranian Population: A Case-control Study. PG - 70-76 LID - 10.30476/IJMS.2022.91192.2241 [doi] AB - BACKGROUND: Genetic diversity in human leukocyte antigen (HLA) alleles across populations is a significant risk factor for drug-induced severe cutaneous adverse reactions (SCARs), e.g., carbamazepine (CBZ)- and lamotrigine (LTG)-induced Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN). The present study aimed to investigate the frequency of different HLA alleles in Iranian patients with CBZ- and LTG-induced SJS/TEN. METHODS: A case-control study was conducted from 2011 to 2018 at various hospitals affiliated with Shiraz University of Medical Sciences (Shiraz, Iran). A total of 31 patients receiving anticonvulsant drugs (CZB or LTG) were recruited and divided into two groups. The drug-induced group (n=14) included hospitalized patients due to CBZ- or LTG-induced SJS/TEN. The drug-tolerant group (n=17) included individuals receiving CBZ or LTG for at least three months with no adverse effects. In addition, 46 healthy individuals (control group) were recruited. The frequency of HLA-A, -B, and -DRB1 alleles in patients with CZB- or LTG-induced SJS/TEN was investigated. HLA typing was performed using the allele-specific polymerase chain reaction method. The Chi square test and Fisher's exact test were used to determine a potential association between SJS/TEN and HLA alleles. P<0.05 was considered statistically significant. RESULTS: CBZ- or LTG-induced SJS/TEN was not significantly associated with HLA alleles. However, HLA-DRB1*01 showed a significantly higher frequency in patients with CBZ-induced SJS/TEN than the CBZ-tolerant patients (30% vs. 9%, P=0.07). CONCLUSION: Overall, no significant association was found between CBZ- or LTG-induced SJS/TEN and HLA alleles. Further large-scale studies are required to substantiate our findings. CI - Copyright: (c) Iranian Journal of Medical Sciences. FAU - Dastgheib, Ladan AU - Dastgheib L AD - Molecular Dermatology Research Center, Department of Dermatology, Shiraz University of Medical Sciences, Shiraz, Iran. FAU - Rostami, Farima AU - Rostami F AD - Student Research Committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. FAU - Gharesi-Fard, Behrouz AU - Gharesi-Fard B AD - Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. FAU - Asadi-Pooya, Ali Akbar AU - Asadi-Pooya AA AD - Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. AD - Jefferson Comprehensive Epilepsy Center, Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. FAU - Namjoo, Saba AU - Namjoo S AD - Blood Transfusion Research Center, High Institute for Education and Research in Transfusion Medicine, Tehran, Iran. FAU - Tahmasebi, Foroozan AU - Tahmasebi F AD - Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. FAU - Hadibarhaghtalab, Maryam AU - Hadibarhaghtalab M AD - Molecular Dermatology Research Center, Department of Dermatology, Shiraz University of Medical Sciences, Shiraz, Iran. LA - eng PT - Journal Article PL - Iran TA - Iran J Med Sci JT - Iranian journal of medical sciences JID - 8104374 RN - 0 (Anticonvulsants) RN - U3H27498KS (Lamotrigine) RN - 0 (HLA-B Antigens) RN - 33CM23913M (Carbamazepine) RN - 12794-10-4 (Benzodiazepines) SB - IM MH - Humans MH - *Anticonvulsants/adverse effects MH - Lamotrigine/adverse effects MH - Iran MH - *Stevens-Johnson Syndrome/genetics MH - Alleles MH - Case-Control Studies MH - HLA-B Antigens/genetics MH - Asian People MH - Carbamazepine/adverse effects MH - Benzodiazepines PMC - PMC9843459 OTO - NOTNLM OT - Anticonvulsants OT - Histocompatibility testing OT - Stevens-Johnson syndrome COIS- None declared. EDAT- 2023/01/24 06:00 MHDA- 2023/01/25 06:00 PMCR- 2023/01/01 CRDT- 2023/01/23 05:13 PHST- 2021/05/26 00:00 [received] PHST- 2021/11/21 00:00 [revised] PHST- 2022/01/30 00:00 [accepted] PHST- 2023/01/23 05:13 [entrez] PHST- 2023/01/24 06:00 [pubmed] PHST- 2023/01/25 06:00 [medline] PHST- 2023/01/01 00:00 [pmc-release] AID - IJMS-48-1 [pii] AID - 10.30476/IJMS.2022.91192.2241 [doi] PST - ppublish SO - Iran J Med Sci. 2023 Jan;48(1):70-76. doi: 10.30476/IJMS.2022.91192.2241.